MRP Capital Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$111K Hold
800
0.1% 94
2025
Q4
$98.2K Buy
+800
New +$97.2K 0.08% 110
2025
Q3
Sell
-100
Closed -$11.1K 210
2025
Q2
$11.1K Buy
+100
New +$10.6K 0.01% 153
2025
Q1
Sell
-100
Closed -$9.24K 223
2024
Q4
$9.24K Buy
+100
New +$9K 0.01% 171
2023
Q3
Sell
-800
Closed -$61.7K 133
2023
Q2
$61.7K Sell
800
-8,886
-92% -$709K 0.06% 149
2023
Q1
$804K Buy
+9,686
New +$802K 0.88% 46

Other funds holding GILD

MRP Capital Investments's GILD Position: Q1 2026 in Review

MRP Capital Investments held its Gilead Sciences (GILD) position steady in Q1 2026 at 800 shares worth $111K. The position accounts for 0.1% of the portfolio, ranked #94.

MRP Capital Investments first reported a position in GILD in Q1 2023 and has held it in 6 quarters since. The position peaked at $804K in Q1 2023. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • MRP Capital Investments held 800 shares of Gilead Sciences worth $111K as of Q1 2026.
  • MRP Capital Investments left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.1% of MRP Capital Investments's portfolio in Q1 2026, its #94 holding.
  • MRP Capital Investments first reported a position in Gilead Sciences in Q1 2023 and has held it in 6 quarters since.
  • MRP Capital Investments's Gilead Sciences position peaked at $804K in Q1 2023.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on MRP Capital Investments's 13F filing for Q1 2026, filed 14 May 2026.